MacroGenics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
CEOScott E. Koenig
CEOScott E. Koenig
Employees341
Employees341
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2000
Founded2000
Employees341
Employees341
MGNX Key Statistics
Market cap101.26M
Market cap101.26M
Price-Earnings ratio-1.81
Price-Earnings ratio-1.81
Dividend yield—
Dividend yield—
Average volume1.76M
Average volume1.76M
High today$1.62
High today$1.62
Low today$1.52
Low today$1.52
Open price$1.57
Open price$1.57
Volume766.50K
Volume766.50K
52 Week high$5.77
52 Week high$5.77
52 Week low$0.9897
52 Week low$0.9897
Analyst ratings
67%
of 6 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
People also own
Based on the portfolios of people who own MGNX. This list is generated using Robinhood data, and it’s not a recommendation.